Differences in transcriptional response underlie why prior vaccination exceeds prior infection in eliciting robust immune responses in Omicron infected outpatients
Preprint
Abstract
Antibody response following Omicron infection is reported to be less robust than that to other variants. Here we investigated how prior vaccination and/or prior infection modulates that response. Disease severity, antibody responses and immune transcriptomes were characterized in four groups of Omicron-infected outpatients (n=83): unvaccinated/no prior infection, vaccinated/no prior infection, unvaccinated/prior infection and vaccinated/prior infection. The percentage of patients with asymptomatic or mild disease was highest in the vaccinated/no prior infection group (87%) and lowest in the unvaccinated/no prior infection group (47%). Significant anti-Omicron spike antibody levels and neutralizing activity were detected in the vaccinated group immediately after infection but were not present in the unvaccinated/no prior infection group. Within two weeks, antibody levels against Omicron, increased. Omicron neutralizing activity in the vaccinated group exceeded that of the prior infection group. No increase in neutralizing activity in the unvaccinated/no prior infection group was seen. The unvaccinated/prior infection group showed an intermediate response. We then investigated the early transcriptomic response following Omicron infection in these outpatient populations and compared it to that found in unvaccinated hospitalized patients with Alpha infection. Omicron infected patients showed a gradient of transcriptional response dependent upon prior vaccination and infection status that correlated with disease severity. Vaccinated patients showed a significantly blunted interferon response as compared to both unvaccinated Omicron infected outpatients and unvaccinated Alpha infected hospitalized patients typified by the response of specific gene classes such as OAS and IFIT that control anti-viral responses and IFI27, a predictor of disease outcome.Keywords
All Related Versions
- Published version: Frontiers in Immunology, 13, 916686.
This publication has 20 references indexed in Scilit:
- Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage studyThe Lancet, 2022
- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodiesNature Medicine, 2022
- Omicron, the great escape artistNature Reviews Immunology, 2022
- USP18 – a multifunctional component in the interferon responseBioscience Reports, 2018
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- HTSeq—a Python framework to work with high-throughput sequencing dataBioinformatics, 2014
- Normalization of RNA-seq data using factor analysis of control genes or samplesNature Biotechnology, 2014
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- ggplot22009